Enovix Statistics
Total Valuation
Enovix has a market cap or net worth of $594.95 million. The enterprise value is $660.89 million.
| Market Cap | 594.95M |
| Enterprise Value | 660.89M |
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Enovix has 214.01 million shares outstanding. The number of shares has increased by 8.59% in one year.
| Current Share Class | 214.01M |
| Shares Outstanding | 214.01M |
| Shares Change (YoY) | +8.59% |
| Shares Change (QoQ) | +0.52% |
| Owned by Insiders (%) | 11.41% |
| Owned by Institutions (%) | 52.30% |
| Float | 189.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.58 |
| Forward PS | 11.40 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 3.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 18.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.71, with a Debt / Equity ratio of 2.56.
| Current Ratio | 9.71 |
| Quick Ratio | 9.19 |
| Debt / Equity | 2.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.62 |
Financial Efficiency
Return on equity (ROE) is -81.28% and return on invested capital (ROIC) is -19.28%.
| Return on Equity (ROE) | -81.28% |
| Return on Assets (ROA) | -17.55% |
| Return on Invested Capital (ROIC) | -19.28% |
| Return on Capital Employed (ROCE) | -23.83% |
| Weighted Average Cost of Capital (WACC) | 11.57% |
| Revenue Per Employee | $54,035 |
| Profits Per Employee | -$256,063 |
| Employee Count | 664 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 1.88 |
Taxes
| Income Tax | -859,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.12% in the last 52 weeks. The beta is 2.48, so Enovix's price volatility has been higher than the market average.
| Beta (5Y) | 2.48 |
| 52-Week Price Change | -72.12% |
| 50-Day Moving Average | 3.55 |
| 200-Day Moving Average | 5.70 |
| Relative Strength Index (RSI) | 38.35 |
| Average Volume (20 Days) | 7,206,934 |
Short Selling Information
The latest short interest is 52.94 million, so 24.74% of the outstanding shares have been sold short.
| Short Interest | 52.94M |
| Short Previous Month | 53.67M |
| Short % of Shares Out | 24.74% |
| Short % of Float | 27.92% |
| Short Ratio (days to cover) | 6.20 |
Income Statement
In the last 12 months, Enovix had revenue of $35.88 million and -$170.03 million in losses. Loss per share was -$0.79.
| Revenue | 35.88M |
| Gross Profit | 6.76M |
| Operating Income | -178.15M |
| Pretax Income | -171.00M |
| Net Income | -170.03M |
| EBITDA | -140.91M |
| EBIT | -178.15M |
| Loss Per Share | -$0.79 |
Balance Sheet
The company has $475.78 million in cash and $541.72 million in debt, with a net cash position of -$65.94 million or -$0.31 per share.
| Cash & Cash Equivalents | 475.78M |
| Total Debt | 541.72M |
| Net Cash | -65.94M |
| Net Cash Per Share | -$0.31 |
| Equity (Book Value) | 211.99M |
| Book Value Per Share | 0.98 |
| Working Capital | 453.63M |
Cash Flow
In the last 12 months, operating cash flow was -$107.38 million and capital expenditures -$16.82 million, giving a free cash flow of -$124.20 million.
| Operating Cash Flow | -107.38M |
| Capital Expenditures | -16.82M |
| Depreciation & Amortization | 37.24M |
| Net Borrowing | 361.09M |
| Free Cash Flow | -124.20M |
| FCF Per Share | -$0.58 |
Margins
| Gross Margin | 18.83% |
| Operating Margin | -496.54% |
| Pretax Margin | -476.61% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Enovix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.59% |
| Shareholder Yield | -8.59% |
| Earnings Yield | -28.58% |
| FCF Yield | -20.88% |
Analyst Forecast
The average price target for Enovix is $11.35, which is 308.27% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.35 |
| Price Target Difference | 308.27% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 91.29% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Enovix has an Altman Z-Score of -0.09 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.09 |
| Piotroski F-Score | 4 |